Clinical Trials Logo

Thyroid clinical trials

View clinical trials related to Thyroid.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03060499 Withdrawn - Thyroid Clinical Trials

Post Thyroidectomy Myocardial Function

TECH
Start date: October 13, 2016
Phase:
Study type: Observational

Protocol Synopsis Protocol title: Post thyroidectomy myocardial function Purpose: Evaluation of the effects of total thyroidectomy on myocardial function Design: Prospective, single-center, cohort study Patient Population: Male or female subjects 18 years of age or older who are scheduled for total thyroidectomy No. of Subjects: 50 patients, estimated up to 12 months to enroll Duration of Treatment: Operation Duration of Follow-up: After discharge, the patients will be re-evaluated at three (3), six (6) and twelve (12) months in the outpatient clinic. Endpoints: To evaluate the changes in the myocardial function after the removal of the thyroid gland.

NCT ID: NCT01396733 Withdrawn - Cancer Clinical Trials

Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer

RALT
Start date: April 2011
Phase: Phase 2
Study type: Interventional

Radioiodine (I-131) therapy is of proven efficacy for treatment of differentiated thyroid carcinoma (DTC). However, loss of differentiation in recurrent or metastatic DTC which decrease I-131 uptake may decrease the efficacy of I-131 therapy. Therefore, strategies to improve I-131 uptake are mandatory. This study is an open label clinical study to evaluate the effectiveness of alpha-lipoic acid (ALA) for improving I-131 uptake in recurrent or metastatic of DTC with defective I-131 uptake.